Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 279-284

  Thor Straten, Per ^a   Becker, Jürgen C ^b   Seremet, Tina ^a   Bröcker, Eva Bettina ^b   Zeuthen, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b Dept of Gastroenterol and Hepatol   (Germany)

Author keywords

HLA A2; immunosurveillance; melanoma; sequence; TCRBV expression

Indexed keywords

COMPLEMENTARY DNA; HLA A2 ANTIGEN; MESSENGER RNA; RNA;

ARTICLE; CANCER SURGERY; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0038081671     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118790     Document Type: Article

References (26)

1. Cole, W.H. 1976. Spontaneous regression of cancer and the importance of finding its cause. Natl. Cancer Inst. Monogr. 44:5-9.
2. thor Straten, P., J. Schøller, K. Hou Jensen, and J. Zeuthen. 1994. Preferential usage of T cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Int. J. Cancer. 56: 78-86.
3. Ferradini, L., S. Roman-Roman, J. Azocar, M.F. Avril, S. Viel, F. Triebel, and T. Hercend. 1992. Analysis of T cell receptor alpha/beta variability in lymphocytes infiltrating a melanoma metastasis. Cancer Res. 52:4649-4654.
4. Salvi, S., F. Segalla, S. Rao, F. Arienti, M. Sanori, G. Bratina, E. Caronni, A. Anichini, C. Clemente, G. Parmiani et al. 1995. Overexpression of the T cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res. 55:3374-3379.
5. Clark, W.H. 1991. Tumour progression and the nature of cancer. Br. J. Cancer. 64:631-644.
6. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
7. Kirkin, A., T.R. Petersen, A.C. Olsen, L. Li, P. thor Straten, and J. Zeuthen. 1995. Generation of human-melanoma specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol. Immunother. 41:71-81.
8. Zemmour, J., and P. Parham. 1993. HLA Class I nucleotide sequences. 1992. Immunobiology. 187:70-101.
9. Johnston, R.F., S.C. Pickett, and D.L. Barker. 1990. Autoradiography using storage phosphor technology. Electrophoresis. 11:355-360.
10. Cole, W.H. 1976. Relationship of causative factors in spontaneous regression of cancer to immunologic factors possibly effective in cancer. J. Surg. Oncol. 8:391-411.
11. Schøller, J., P. thor Straten, A. Birck, E. Siim, K. Dahlstrøm, K.T. Drzewiecki, and J. Zeuthen. 1994. Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions. Cancer Immunol Immunother 39:239-248.
12. Mackensen, A., L. Ferradini, G. Carcelain, F. Triebel, F. Faure, S. Viel, and T. Hercend. 1993. Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res. 53: 3569-3573.
13. Sensi, M., and G. Parmiani. 1995. Analysis of TCR usage in human tumor:a new tool for assessing tumor-specific immune responses. Immunol. Today. 16:588-595.
14. Kelly, J.W., R.W. Sagebiel, and M.S. Blois. 1985. Regression in malignant melanoma. A histologic feature without independent prognostic significance. Cancer. 56:2287-2291.
15. Weidmann, E., E.M. Elder, M. Trucco, M.T. Lotze, and T.L. Whiteside. 1993. Usage of T cell receptor V beta chain genes in fresh and cultured tumor-infiltrating lymphocytes from human melanoma. Int. J. Cancer. 54:383-390.
16. Russo, V., C. Traversari, A. Verrecchia, M. Mottolese, P.G. Natali, and C. Bordignon. 1995. Expression of the MAGE gene family in primary and metastatic human breast cancer: implications for tumor antigen-specific immunotherapy. Int. J. Cancer. 64:216-221.
17. Ferrone, S., and F. M. Marincola. 1995. Loss of HLA class I antigens by melanoma cells:molecular mechanisms, functional significance and clinical relevance. Immunol. Today. 16:487-494.
18. Lehmann, F., M. Marchand, P. Hainaut, P. Pouillart, X. Sastre, H. Ikeda, T. Boon, and P.O. Coulie. 1995. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol. 25:340-347.
19. Nanda, N.K., K.K. Arzoo, H.M. Geysen, A. Sette, and E.E. Sercarz. 1995. Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 182:531-539.
20. Nanda, N.K., K.K. Arzoo, and E.E. Sercarz. 1992. In a small multideterminant peptide, each determinant is recognized by a different V beta gene segment. J. Exp. Med. 176:297-302.
21. Cole, D.J., D.P. Weil, P. Shamamian, L. Rivoltini, Y. Kawakami, S. Topalian, C. Jennings, S. Eliyahu, S.A. Rosenberg, and M.I. Nishimura. 1994. Identification of MART-1-specific T cell receptors: T cells utilizing distinct T cell receptor variable and joining regions recognize the same tumor epitope. Cancer Res. 54:5265-5268.
22. Romero, P., C. Pannetier, J. Herman, C.V. Jongeneel, J.C. Cerottini, and P.G. Coulie. 1995. Multiple specificities in the repertoire of a melanoma patients cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1. J. Exp. Med. 182:1019-1028.
23. Sensi, M., C. Traversari, M. Radrizzani, S. Salvi, C. Maccalli, R. Mortarini, L. Rivoltini, C. Farina, G. Nicolini, T. Wölfel et al. 1995. Cytotoxic T-lymphocyte clones from different patients display limited T cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1. Proc. Natl. Acad. Sci. USA. 92:5674-5678.
24. Lüscher, U., L. Filgueira, A. Juretic, M. Zuber, N.J. Lüscher, M. Heberer, and G.C. Spagnoli. 1994. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests a state of reversible anergy of tumor-infiltrating lymphocytes. Int. J. Cancer. 57:612-619.
25. Becker, J.C., C. Czerny, and E.B. Bröcker. 1994. Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol. 6:1605-1612.
26. Kurt, R.A., J.A. Park, M.C. Panelli, S.F. Schluter, J.J. Marchalonis, B. Carolus, and E.T. Akporiaye. 1995. T lymphocytes infiltrating sites of tumor rejection and progression display identical V beta usage but different cytotoxic activities. J. Immunol 154:3969-3974.